Atlas Trials

Pharmacodynamics and Tolerance of Nicotinamide Mononucleotide (NMN, 400mg/Day) in Healthy Adults

Clinical trial NCT04862338 · COMPLETED

Trial details

NCT number
NCT04862338
Sponsor
Seneque SA
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2021-04-26
Primary completion
2021-09-08
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.